Navigation Links
Anasys licenses ORNL nanoscale mass spectrometry imaging technology
Date:4/14/2014

OAK RIDGE, Tenn., April 14, 2014 Anasys Instruments Corp. has licensed a Department of Energy Oak Ridge National Laboratory technology that allows for simultaneous chemical and physical characterization and could lead to advances in materials and drug development.

The technique, which combines the power of atomic force microscopy and mass spectrometry, fills a void and streamlines analytical processes that are vital to science and industry, said Roshan Shetty, chief executive officer of Anasys Instruments. He also noted that the technology improves the current spatial resolution of ambient methods for mass spectrometry imaging by a factor of more than 100, resulting in imaging resolution as small as 250 nanometers, or 1/400th the thickness of a human hair.

"This capability could have a tremendous impact on a broad field of applications in materials and life sciences ranging from single-cell imaging to polymer composites," Shetty said.

The license is the culmination of several years of research by a team led by Gary Van Berkel of ORNL's Chemical Sciences Division. The team's research has focused on mass spectrometry-based imaging pushing toward nanoscale imaging at ambient conditions using atomic force microscopy.

"No other group has these capabilities, and this research distinction made Oak Ridge National Laboratory the ideal partner," Shetty said.

Van Berkel noted that the patented technique opens a world of opportunities.

"This new capability allows us to map, for instance, the degradation of organic compound-based solar cells at the chemical level, the metabolites produced from living bacterial colonies and the distribution of dosed pharmaceuticals and their metabolites in tissues and cells," Van Berkel said.

Measurements of physical and chemical processes using these new tools could provide the knowledge required to boost research in areas ranging from energy materials to drug discovery, accordi
'/>"/>

Contact: Ron Walli
wallira@ornl.gov
865-576-1946
DOE/Oak Ridge National Laboratory
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Inflection Biosciences licenses preclinical oncology programs from the CNIO
2. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
3. DNA helicity and elasticity explained on the nanoscale
4. Researchers use nanoscale patches to sensitize targeted cell receptors
5. Diamond flaws pave way for nanoscale MRI
6. Wonder of Nanotechnology details research enabling nanoscale optoelectronic devices
7. Team creates MRI for the nanoscale
8. Stem cell breakthrough could lead to new bone repair therapies on nanoscale surfaces
9. Researchers create flexible, nanoscale bed of nails for possible drug delivery
10. A nanoscale window to the biological world
11. New NIH/NHGRI grants to harness nanoscale technologies to cut DNA sequencing costs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Anasys licenses ORNL nanoscale mass spectrometry imaging technology
(Date:9/18/2014)... tropical rabbitfish which have devastated algal forests in the ... entire Mediterranean basin if their distribution continues to expand ... study, by an international team of researchers led by ... Tomas of the Mediterranean Institute for Advanced Studies in ... ., Members of the team surveyed more than 1000 ...
(Date:9/18/2014)... form of camouflage: you don,t just blend in, the ... as uncommon as you might think. Kathryn Feller, from ... the larval life stages of many marine species are ... that most creatures cannot make transparent. Feller explains that ... individual eye unit with an opaque pigment to prevent ...
(Date:9/17/2014)... Humanities has received a $260,000 grant from the Andrew ... of the Human in the Age of the Life ... of events aimed at exploring two compelling themes in ... who are exploring the boundaries of our self-definition as ... other involves the increasingly influential hypothesis that we are ...
Breaking Biology News(10 mins):Tropical fish a threat to Mediterranean Sea ecosystems 2Transparent larvae hide opaque eyes behind reflections 2Mellon Foundation awards grant for major project in the humanities and sciences 2
... are two root causes of a type of diabetes associated ... a clinical trial, may guide development of new treatments or ... Almost half of patients with CF will develop diabetes by ... their teens. In addition to the health problems caused by ...
... CORVALLIS, Ore. Diatoms, tiny marine life forms that ... biofuel production from algae truly cost-effective because they ... biomedical products and even health foods. Engineers at ... the envelope a bit. But it,s not science fiction ...
... and pregnant, your baby isn,t destined to a life of ... online in The FASEB Journal . In ... fat intake during pregnancy to a moderate level is enough ... they found that a protein called "SIRT1" rewrites a developing ...
Cached Biology News:Cystic fibrosis disrupts pancreas two ways in CF-related diabetes 2Cystic fibrosis disrupts pancreas two ways in CF-related diabetes 3Ancient diatoms could make biofuels, electronics and health food -- at the same time 2Eating well during pregnancy reduces baby's obesity risk regardless of mom's size 2
(Date:9/20/2014)... HealthTronics, Inc. , a ... products and services, has signed a distribution agreement ... Corporation for its high precision laser technology. ... invasive, mobile, surgical technology—offering more choices for healthcare ... HealthTronics will make available Clinicon’s FDA-cleared SureLase™ CO2 ...
(Date:9/19/2014)... rather than electricity, to move data would consume ... a growing concern as chips, transistor counts rise. ... circuits light emitters, modulators, and detectors ... light source for optical chips is molybdenum disulfide ... as a single, atom-thick layer. Other experimental on-chip ...
(Date:9/19/2014)... -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology ... to manufacture proteins including biosimilar therapeutics, today announced that ... Annual NewsMakers in the Biotech Industry conference in ... chief executive officer of Pfenex, will provide an overview ... Friday, September 26, 2014 at 10:00 a.m. EDT/7:00 a.m. ...
(Date:9/19/2014)... , September 19, 2014 , ... European Society for Paediatric Endocrinology (ESPE) Meeting  ... and medical research in the field of growth  , ... Darmstadt, Germany , today announced the ... for 2014. The awards were announced during a Satellite ...
Breaking Biology Technology:HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Toward optical chips 2Toward optical chips 3Pfenex to Present at Upcoming Industry Conference on September 26 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3
... by Rice University has brought a wealth of new information ... The current issue of the American Chemical Society journal ... the Rice lab of chemist Bruce Weisman to understand how ... in this case, the light they emit at near-infrared ...
... Realty Trust, Inc. (NYSE: BMR ) today announced ... ended December 31, 2011 after the market closes on Wednesday, ... and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive ... host an investor conference call at 10:00 a.m. Pacific Time ...
... DURHAM, N.C., Jan. 31, 2012  Argos Therapeutics Inc., ... immune monitoring analysis of AGS-003-006, a Phase 2 ... with sunitinib in patients with advanced renal cell ... correlation between anti-tumor memory T cell responses and ...
Cached Biology Technology:Perfect nanotubes shine brightest 2BioMed Realty Trust to Report 2011 Fourth Quarter and Year End Results 2Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC) 2Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC) 3
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
... Antigen peptide transporter 2 ... (Peptide transporter PSF2) (Peptide ... (Peptide transporter involved in ... Antigen: ...
This monoclonal antibody recognizes the light chain of human Factor XII and at 100 nM inhibits 50% of Factor XII activity. It may be used in ELISA to detect human Factor XII and in coagulation assay...
Anti-LC3 Polyclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...
Biology Products: